Crossmark

Effectiveness of the antiviral medications azvudine and nirmatrelvir-ritonavir in treating COVID-19 in patients with hematological malignancies

Crossref DOI link: https://doi.org/10.1016/j.clinsp.2024.100406

Published Print: 2024-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Zeng, Zheng http://orcid.org/0000-0002-5844-3125
Li, Fangyuan

Zhong, Mingli

Zhu, Ling

Chen, Wei

Wang, Xiaotao
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82060044)

Natural Science Foundation of Guangxi Province (2020GXNSFBA297005, 2020GXNSFAA159018)
License Information

Text and Data Mining valid from 2024-01-01

Text and Data Mining valid from 2024-01-01

Version of Record valid from 2024-05-28
More Information

This article is maintained by: Elsevier

Article Title: Effectiveness of the antiviral medications azvudine and nirmatrelvir-ritonavir in treating COVID-19 in patients with hematological malignancies

Journal Title: Clinics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.clinsp.2024.100406

Content Type: article

Copyright: © 2024 Published by Elsevier España, S.L.U. on behalf of HCFMUSP.